Musculoskeletal simulation can help explain selective muscle degeneration in Duchenne muscular dystrophy.
about
A Novel NF-κB Inhibitor, Edasalonexent (CAT-1004), in Development as a Disease-Modifying Treatment for Patients With Duchenne Muscular Dystrophy: Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics in Adult SubjectsAre mice good models for human neuromuscular disease? Comparing muscle excursions in walking between mice and humans.Skeletal muscle contractile properties in a novel murine model for limb girdle muscular dystrophy 2i.Multi-slice MRI reveals heterogeneity in disease distribution along the length of muscle in Duchenne muscular dystrophy.
P2860
Musculoskeletal simulation can help explain selective muscle degeneration in Duchenne muscular dystrophy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Musculoskeletal simulation can ...... n Duchenne muscular dystrophy.
@ast
Musculoskeletal simulation can ...... n Duchenne muscular dystrophy.
@en
type
label
Musculoskeletal simulation can ...... n Duchenne muscular dystrophy.
@ast
Musculoskeletal simulation can ...... n Duchenne muscular dystrophy.
@en
prefLabel
Musculoskeletal simulation can ...... n Duchenne muscular dystrophy.
@ast
Musculoskeletal simulation can ...... n Duchenne muscular dystrophy.
@en
P2860
P356
P1433
P1476
Musculoskeletal simulation can ...... n Duchenne muscular dystrophy.
@en
P2093
P2860
P304
P356
10.1002/MUS.24607
P577
2015-06-03T00:00:00Z